Starling Oncology Institute, Inc. Common Stock
STLN
39 hedge funds and large institutions have $8.83M invested in Starling Oncology Institute, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 12 closing their positions.
1.72% more ownership
Funds ownership: 23.4% → 25.12% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 47 → 39 (-8)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
69% less capital invested
Capital invested by funds: $28.2M → $8.83M (-$19.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAS
TIFF Advisory Services
Radnor,
Pennsylvania
|
+$849K |
| 2 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$481K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$204K |
| 4 |
Renaissance Technologies
New York
|
+$170K |
| 5 |
BlackRock
New York
|
+$47.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KMC
Kirr Marbach & Co
Columbus,
Indiana
|
-$331K |
| 2 |
EPA
Element Pointe Advisors
Miami,
Florida
|
-$314K |
| 3 |
Squarepoint
New York
|
-$167K |
| 4 |
TM
Triatomic Management
Palo Alto,
California
|
-$69.8K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$60K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$64 | +75 | +136% |
|
STLN Hedge Fund Activity: Q2 2024 in Review
39 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Institute, Inc. Common Stock (STLN) for Q2 2024, worth a combined $8.83M — down 69% from $28.2M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of STLN and 4 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 9 added.
The largest buyer was TIFF Advisory Services, adding an estimated $849K. The largest seller was Kirr Marbach & Co, exiting entirely with an estimated $331K sold.
- 39 institutional investors held Starling Oncology Institute, Inc. Common Stock (STLN) as of Q2 2024, down from 47 in Q1 2024.
- Funds reported $8.83M of Starling Oncology Institute, Inc. Common Stock stock for Q2 2024, down 69% quarter-over-quarter.
- 4 funds opened new Starling Oncology Institute, Inc. Common Stock positions in Q2 2024 and 12 closed out, a net change of -8 holders.
- The largest Starling Oncology Institute, Inc. Common Stock buyer in Q2 2024 was TIFF Advisory Services, an estimated $849K added.
- The largest Starling Oncology Institute, Inc. Common Stock seller in Q2 2024 was Kirr Marbach & Co, an estimated $331K sold.
Based on aggregated 13F filings for Q2 2024.